Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asian Phytoceuticals PCLBKK:APCO-R 63 EV-to-Revenue is 6.21 as of Aug. 29, 2026, which is 32% below its 10-year median of 9.07. GuruFocus rates BKK:APCO-R with a GF Score™ of 63/100 and a GF Value™ of ฿7.81. The stock has 4 warning signs investors should review. Among 1,958 Consumer Packaged Goods companies, Asian Phytoceuticals PCL ranks worse than 91.62% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Asian Phytoceuticals PCL's enterprise value is ฿1,220.5 Mil.
Asian Phytoceuticals PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ฿196.7 Mil. Therefore, Asian Phytoceuticals PCL's EV-to-Revenue for today is 6.21.
The historical rank and industry rank for Asian Phytoceuticals PCL's EV-to-Revenue or its related term are showing as below:
BKK:APCO-R'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.92 Med: 9.07 Max: 21.8
Current: 6.2
During the past 13 years, the highest EV-to-Revenue of Asian Phytoceuticals PCL was 21.80. The lowest was 3.92. And the median was 9.07.
BKK:APCO-R's EV-to-Revenue is ranked worse than 91.62% of 1958
companies
in the Consumer Packaged Goods industry
Industry Median: 1.08
vs BKK:APCO-R: 6.20
Asian Phytoceuticals PCL's share price for today is ฿6.2739.
Asian Phytoceuticals PCL's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL EV-to-Revenue Related Terms
Asian Phytoceuticals PCL EV-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: EV-to-Revenue Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL EV-to-Revenue vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's EV-to-Revenue falls into.
Asian Phytoceuticals PCL's current Enterprise Value is ฿1,220.5 Mil.
Asian Phytoceuticals PCL's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿196.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a EV-to-Revenue of 6.21 as of Aug. 29, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Asian Phytoceuticals PCL and its competitors. This is 32% below median its historical median of 9.07. Over the past decade, Asian Phytoceuticals PCL's EV-to-Revenue has ranged from 3.92 to 21.80. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #1794 out of 1958 companies in the Consumer Packaged Goods industry, placing it in the top 91.6%.
Is Asian Phytoceuticals PCL's EV-to-Revenue too high?
Asian Phytoceuticals PCL's current EV-to-Revenue of 6.21 is 32% below median its 10-year median of 9.07. Over the past 10 years, this metric has ranged from a low of 3.92 to a high of 21.80. The Consumer Packaged Goods industry median EV-to-Revenue is 1.08. Asian Phytoceuticals PCL's value of 6.21 is 475% above this industry median. Based on the distribution chart, Asian Phytoceuticals PCL ranks #1794 out of 1958 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's EV-to-Revenue compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #1794 out of 1958 companies for EV-to-Revenue. This places Asian Phytoceuticals PCL in the lower half of its industry. The industry median EV-to-Revenue is 1.08. Asian Phytoceuticals PCL's value of 6.21 is 475% above this benchmark. Historically, Asian Phytoceuticals PCL's own EV-to-Revenue has ranged from 3.92 to 21.80 over the past decade. While the company's 10-year median is 9.07 vs. the industry median of 1.08, Asian Phytoceuticals PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Consumer Packaged Goods company?
The median EV-to-Revenue among Consumer Packaged Goods companies is 1.08, based on 1,958 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asian Phytoceuticals PCL's current EV-to-Revenue of 6.21 is 475% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median EV-to-Revenue is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current EV-to-Revenue is 6.21, which is 32% below median its own 10-year median of 9.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current EV-to-Revenue of 6.21. The stock's GF Value™ is ฿7.81, compared to a current price of ฿6.27 — trading 19.7% below its estimated fair value. The current EV-to-Revenue is 6.21, which is 32% below median its 10-year median of 9.07 and 475% above the Consumer Packaged Goods industry median of 1.08. Asian Phytoceuticals PCL's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current EV-to-Revenue is 6.21 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 19.7% below its estimated GF Value™ of ฿7.81.
Key valuation signals for BKK:APCO-R:
EV-to-Revenue: 6.21 (32% below median its 10-year median of 9.07)
GF Value™: ฿7.81 vs. price of ฿6.27 (19.7% below fair value)
Industry Position: 475% above the Consumer Packaged Goods median (#1794 of 1958)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
63GF Score
Get the complete analysis for BKK:APCO-R
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
